0      0


Human Neutralizing Antibodies Elicited by SARS‑CoV‑2 Infection


‐ Jan 13, 2021 10:40am

Speaker(s):

You must be logged in and own this session in order to post comments.

Leo OzurumbaDwight
1/13/21 11:02 am

Good day sir. I commend your study and effort put in. These are my questions and suggestions: Do they have different approach to identification and development ? 1) How can the efficacy of these antibodies be optimized to help and support treatment options ? Thank you. Warm regards. Leo Ozurumba-Dwight Walden University MN